Skip to content

Prof. Charles Craddock, CBE, discusses paradigm trial, transplant advances at ASH 2025
Assay targeting KMT2A rearrangements in AML now available
FDA issues draft guidance on MRD, CR endpoints in MM clinical trials
Dr. Tara Graff presents ‘Implementing bispecific antibodies in community practice’
Dr. Bor-Sheng Ko discusses the future of SOHO Asia and regional collaborations

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Jerald Radich, MD

Cellular Therapy

Jerald Radich, MD

Leukemia

Jerald Radich, MD

Lymphoma

Jerald Radich, MD

Multiple Myeloma

Jerald Radich, MD

Myelodysplastic Syndromes

Jerald Radich, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

February 18, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Jerald Radich, MD

Jerry Radich of fred hutch

Jerald Radich, MD

by sohonews
October 16, 2024
0 Comments
Less than a minute
505 Views
1 year ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

Charles Craddock

ASH 2025, Acute Myeloid Leukemia, News

Prof. Charles Craddock, CBE, discusses paradigm trial, transplant advances

February 17, 2026

Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, News

Assay targeting KMT2A rearrangements in AML now available

February 16, 2026

FDA editorial

Multiple Myeloma, News

FDA issues draft guidance on MRD, CR endpoints in

February 16, 2026

SOHO Insider podcast

Past Sessions, Trending now, Community Oncology, Cellular Therapy, Lymphoma, News, Video Interviews

Dr. Tara Graff presents ‘Implementing bispecific antibodies in community

February 15, 2026

Bor-Sheng Ko

SOHO Asia 2026, Ambassador Program, News, Video Interviews

Dr. Bor-Sheng Ko discusses the future of SOHO Asia

February 13, 2026

Community Oncology News, Past Sessions, Trending now, Community Oncology, Cellular Therapy, Video Interviews

Video: Dr. Graff on implementing bispecific antibodies in community

February 13, 2026

Top Categories

Cellular Therapy

49

Leukemia

82

Lymphoma

88

Multiple Myeloma

76

Myelodysplastic Syndromes

28

Myeloproliferative Neoplasms

18

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Jerald Radich, MD

Cellular Therapy

Jerald Radich, MD

Leukemia

Jerald Radich, MD

Lymphoma

Jerald Radich, MD

Multiple Myeloma

Jerald Radich, MD

Myelodysplastic Syndromes

Jerald Radich, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Charles Craddock

Prof. Charles Craddock, CBE, discusses paradigm trial, transplant advances at ASH 2025

Assay targeting KMT2A rearrangements in AML now available

FDA editorial

FDA issues draft guidance on MRD, CR endpoints in MM clinical trials

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.